GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:17911384

From GONUTS
Jump to: navigation, search
Citation

Park, SO, Lee, YJ, Seki, T, Hong, KH, Fliess, N, Jiang, Z, Park, A, Wu, X, Kaartinen, V, Roman, BL and Oh, SP (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111:633-42

Abstract

ALK1 belongs to the type I receptor family for transforming growth factor-beta family ligands. Heterozygous ALK1 mutations cause hereditary hemorrhagic telangiectasia type 2 (HHT2), a multisystemic vascular disorder. Based largely on in vitro studies, TGF-beta1 has been considered as the most likely ALK1 ligand related to HHT, yet the identity of the physiologic ALK1 ligand remains controversial. In cultured endothelial cells, ALK1 and another TGF-beta type I receptor, ALK5, regulate angiogenesis by controlling TGF-beta signal transduction, and ALK5 is required for ALK1 signaling. However, the extent to which such interactions between these 2 receptors play a role in pathogenesis of HHT is unknown. We directly addressed these issues in vivo by comparing the phenotypes of mice in which the Alk1, Alk5, or Tgfbr2 gene was conditionally deleted in restricted vascular endothelia using a novel endothelial Cre transgenic line. Alk1-conditional deletion resulted in severe vascular malformations mimicking all pathologic features of HHT. Yet Alk5- or Tgfbr2-conditional deletion in mice, or Alk5 inhibition in zebrafish, did not affect vessel morphogenesis. These data indicate that neither ALK5 nor TGFBR2 is required for ALK1 signaling pertinent to the pathogenesis of HHT and suggest that HHT might not be a TGF-beta subfamily disease.

Links

PubMed PMC2200847 Online version:10.1182/blood-2007-08-107359

Keywords

Activin Receptors, Type I/genetics; Activin Receptors, Type I/metabolism; Animals; Cell Line; Endothelium, Vascular/metabolism; Endothelium, Vascular/pathology; Ligands; Mice; Mice, Knockout; Neovascularization, Pathologic/genetics; Neovascularization, Pathologic/metabolism; Neovascularization, Pathologic/pathology; Protein-Serine-Threonine Kinases/genetics; Protein-Serine-Threonine Kinases/metabolism; Receptors, Transforming Growth Factor beta/genetics; Receptors, Transforming Growth Factor beta/metabolism; Signal Transduction/genetics; Telangiectasia, Hereditary Hemorrhagic/genetics; Telangiectasia, Hereditary Hemorrhagic/metabolism; Telangiectasia, Hereditary Hemorrhagic/pathology; Transforming Growth Factor beta1/genetics; Transforming Growth Factor beta1/metabolism; Zebrafish/genetics; Zebrafish/metabolism; Zebrafish Proteins

Significance

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status


See also

References

See Help:References for how to manage references in GONUTS.